Cargando…
Alternative and New Radiopharmaceutical Agents for Lung Cancer
BACKGROUND: FDG PET/CT imaging has an established role in lung cancer (LC) management. Whilst it is a sensitive technique, FDG PET/CT has a limited specificity in the differentiation between LC and benign conditions and is not capable of defining LC heterogeneity since FDG uptake varies between hist...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206190/ https://www.ncbi.nlm.nih.gov/pubmed/31868150 http://dx.doi.org/10.2174/1874471013666191223151402 |